Sensitivity to Glucantime® of Leishmania Viannia isolated from patients prior to treatment

Journal of Parasitology

Volumn 85, Issue 2, 1999, Pages 360-366

  Robledo, Sara M ^a   Valencia, Anais Zully ^a,b   Saravia, Nancy G ^a  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY DERIVATIVE; MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

AMASTIGOTE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PARASITE ISOLATION; PROMASTIGOTE; SKIN LEISHMANIASIS; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; LEISHMANIA; PARASITOLOGY;

ANIMALS; ANTIPROTOZOAL AGENTS; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

EID: 0032586779     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.2307/3285647     Document Type: Article

References (27)

1. AITCHISON, J., AND S. D. SILVEY. 1957. The generalization of probit analysis to the case of multiple responses. Biometrika 44: 131-140.
2. BADARO, R., AND D. J. WARREN, JR. 1993. The role of interferon-t in the treatment of visceral and diffuse cutaneous leishmaniasis. Journal of Infectious Diseases 167: S13-S17.
3. BALLOU, W. R., J. B. MCCLAIN, D. M. GORDON, ET AL. 1987. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 2: 13-16.
4. BERGER, B. J., AND A. H. FAIRLAMB. 1992. Interactions between immunity and chemotherapy in the treatment of the Trypanosomiases and Leishmaniases. Parasitology 105: S71-S78.
5. BERMAN, J. D., AND D. J. WYLER. 1980. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. Journal of Infectious Disease 142: 83-86.
6. _, J. D. CHULAY, L. D. HENDRICKS, AND C. N. OSTER. 1982. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro. American Journal of Tropical Medicine and Hygiene 31: 459-465.
7. _, N. EDWARDS, M. KING, AND M. GROGL. 1989. Biochemistry of Pentostam® resistant Leishmania. American Journal of Tropical Medicine and Hygiene 40: 159-164.
8. CHULAY, J. D., L. FLECKENSTEIN, AND D. H. SMITH. 1988. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Transactions of the Royal Society of Tropical Medicine and Hygiene 82:69-72.
9. CONVIT, J., P. L. CASTELLANOSA, M. ULRICH, M. CASTES, A. RONDON, M. E. PINARDI, N. RODRIGUEZ, B. R. BLOOM, S. FORMICA, L. VALECILLOS, AND A. BRETAÑA. 1989. Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. Journal of Infectious Diseases 160: 104-115.
10. DANIEL, W. W. 1987. Biostatistics: A foundation for analysis in the health sciences, 4th ed. John Wiley & Sons, New York, New York, 734 p.
11. EPHROS, M., E. WALDMAN, AND D. ZILBERSTEIN. 1997. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrobial Agents and Chemotherapy 41: 1064-1068.
12. GROGL, M., A. M. J. ODULA, L. D. C. CORDERO, AND D. E. KYLE. 1989. Leishmania spp.: Development of Pentostam-resistant clones in vitro by discontinuous drug exposure. Experimental Parasitology 69: 78-90.
13. _, T. N., THOMASON, AND E. D. FRANKE. 1992. Drug resistance in leishmaniasis: Its implications in systemic chemotherapy of cutaneous and mucocutaneous disease. American Journal of Tropical Medicine and Hygiene 47: 117-126.
14. HERWALDT, B., AND J. D. BERMAN. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam®) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene 46: 296-306.
15. JACKSON, J. E., J. D. TALLY, AND D. B. TANG. 1989. An in vitro micromethod for drug sensitivity testing of Leishmania. American Journal of Tropical Medicine and Hygiene 41: 318-330.
16. _, J. D. TALLY, W. Y. ELLIS, Y. B. MEBRAHTU, P. G. LAWYER, J. B. WERE, S. G. REED, D. M. PANISKO, AND B. M. LIMMER. 1990. Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania spp. from patients unresponsive to pentavalent antimony therapy. American Journal of Tropical Medicine and Hygiene 43: 464-480.
17. LUCUMI, A., S. ROBLEDO, V. GAMA, AND N. G. SARAVIA. 1998. Sensitivity of Leishmania to pentavalent antimony is correlated with inhibition of topoisomerase. Antimicrobial Agents and Chemotherapy. Antimicrobial Agents and Chemistry 42: 1990-1995.
18. MEADE, J. C., T. A. GLASER, P. F. BONVENTRE, AND A. J. MUKKADA. 1984. Enzymes of carbohydrate metabolism in Leishmania donovani amastigotes. Journal of Protozoology 31: 156-161.
19. MEBRAHTU, Y., P. LAWYER, J. GITHURE, J. B. WERE, R. MUIGAI, L. HENDRICKS, J. LEEUWENBURG, D. KOECH, AND C. ROBERTS. 1989. Visceral leishmaniasis unresponsive to Pentostam® caused by Leishmania tropica in Kenya. American Journal of Tropical Medicine and Hygiene 41: 289-294.
20. MOTTRAM, J. C., AND G. H. COOMBS. 1985. Leishmania mexicana: Enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals. Experimental Parasitology 59: 151-160.
21. ROBERTS, W. L., AND P. M. RAINEY. 1993. Antileishmanial activity of sodium stibogluconate fractions. Antimicrobial Agents and Chemotherapy 37: 1842-1846.
22. ROBLEDO, S. M., A. O. WOZENCRAFT, A. Z. VALENCIA, AND N. G. SARAVIA. 1994. Human monocyte infection by Leishmania (Viannia) panamensis: Role of complement receptors and correlation of susceptibility in vitro with clinical phenotype. Journal of Immunology 152: 1265-1276.
23. ROCHA, R. A., R. N. SAMPAIO, M. GUERRA, A. MAGALHAES, C. C. CUBA, A. C .BARRETO, AND P. D. MARSDEN. 1980. Apparent Glucantime® failure in five patients with mucocutaneous leishmaniasis. Journal of Tropical Medicine and Hygiene 83: 131-139.
24. SENEKJIE, H. A. 1939. Studies on the culture of Leishmania tropica. Transaction of the Royal Society of Tropical Medicine and Hygiene 33: 267.
25. SUNDSTROM, C., AND K. NILSSON. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). International Journal of Cancer 17: 565-577.
26. ULLMAN, B., E. CARRERO-VALENZUELA, AND T. COONS. 1989. Leishmania donovani: Isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines. Experimental Parasitology 69: 157-163.
27. UNDP/WORLD BANK/WHO. 1991-1992. Special program for research and training in tropical disease, 11th program report. World Health Organization, Geneva, Switzerland.